AAAAAA

   
Results: 1-11 |
Results: 11
Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy
Authors: McHutchison, JG Shad, JA Gordon, SC Morgan, TR Ling, MH Garaud, JJ Albrecht, JK Dienstag, JL
Citation: Jg. Mchutchison et al., Predicting response to initial therapy with interferon plus ribavirin in chronic hepatitis C using serum HCV RNA results during therapy, J VIRAL HEP, 8(6), 2001, pp. 414-420
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plusribavirin for initial treatment of chronic hepatitis C: a randomised trial
Authors: Manns, MP McHutchinson, JG Gordon, SC Rustgi, VK Shiffman, M Reindollar, R Goodman, ZD Koury, K Ling, MH Albrecht, JK
Citation: Mp. Manns et al., Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plusribavirin for initial treatment of chronic hepatitis C: a randomised trial, LANCET, 358(9286), 2001, pp. 958-965
Molecular characterization of an anti-epilepsy peptide from the scorpion Buthus martensi Karsch
Authors: Wang, CG He, XL Shao, F Liu, W Ling, MH Wang, DC Chi, CW
Citation: Cg. Wang et al., Molecular characterization of an anti-epilepsy peptide from the scorpion Buthus martensi Karsch, EUR J BIOCH, 268(8), 2001, pp. 2480-2485
A la carte interferon for hepatitis C? Reply
Authors: Poynard, T McHutchison, J Goodman, Z Ling, MH Albrecht, J
Citation: T. Poynard et al., A la carte interferon for hepatitis C? Reply, HEPATOLOGY, 32(3), 2000, pp. 679-679
Clinical utility of early viral load quantification - Reply
Authors: Poynard, T McHutchison, J Goodman, Z Ling, MH Albrecht, J
Citation: T. Poynard et al., Clinical utility of early viral load quantification - Reply, HEPATOLOGY, 32(1), 2000, pp. 158-158
Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?
Authors: Poynard, T McHutchison, J Goodman, Z Ling, MH Albrecht, J
Citation: T. Poynard et al., Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C?, HEPATOLOGY, 31(1), 2000, pp. 211-218
Genomic organization of three novel toxins from the scorpion Buthus martensi Karsch that are active on potassium channels
Authors: Dai, L Wu, JJ Gu, YH Lan, ZD Ling, MH Chi, CW
Citation: L. Dai et al., Genomic organization of three novel toxins from the scorpion Buthus martensi Karsch that are active on potassium channels, BIOCHEM J, 346, 2000, pp. 805-809
Nonhistone protein purified from porcine kidney acts as a suicide substrate inhibitor on furin-like enzyme
Authors: Fei, H Li, Y Wang, LX Luo, MJ Ling, MH Chi, CW
Citation: H. Fei et al., Nonhistone protein purified from porcine kidney acts as a suicide substrate inhibitor on furin-like enzyme, ACT PHAR SI, 21(3), 2000, pp. 265-270
Cost-effectiveness of 24 or 48 weeks of interferon alpha-2b alone or with ribavirin as initial treatment of chronic hepatitis C
Authors: Wong, JB Poynard, T Ling, MH Albrecht, JK Pauker, SG
Citation: Jb. Wong et al., Cost-effectiveness of 24 or 48 weeks of interferon alpha-2b alone or with ribavirin as initial treatment of chronic hepatitis C, AM J GASTRO, 95(6), 2000, pp. 1524-1530
Expression and purification of the BmK M1 neurotoxin from the scorpion Buthus martensii Karsch
Authors: Shao, F Xiong, YM Zhu, RH Ling, MH Chi, CW Wang, DC
Citation: F. Shao et al., Expression and purification of the BmK M1 neurotoxin from the scorpion Buthus martensii Karsch, PROT EX PUR, 17(3), 1999, pp. 358-365
The cDNA sequence of an excitatory insect selective neurotoxin from the scorpion Buthus martensi Karsch
Authors: Xiong, YM Ling, MH Lan, ZD Wang, DC Chi, CW
Citation: Ym. Xiong et al., The cDNA sequence of an excitatory insect selective neurotoxin from the scorpion Buthus martensi Karsch, TOXICON, 37(2), 1999, pp. 335-341
Risultati: 1-11 |